LAUSR

Objectives. The purpose of this study was to analyze the possible costs and economic efficiency of genetic screening in the framework of prenatal diagnostics by identifying the key factors that cause the occurrence of costs in this area. Materials and methods. Analytical reviews and doctrinal sources of Australia, great Britain, Canada and the United States are studied. Methods used: general philosophical, general scientific, private scientific, special. Results. The key factors that cause the emergence of costs in the field of genetic screening in the framework of prenatal diagnostics, which must be taken into account when assessing its economic efficiency, are identified. Conclusions. It is summarized that the affordable state program of genetic screening within the framework of prenatal diagnostics in the future will recoup the costs in terms of reducing the incidence of severe hereditary diseases, for the treatment of which significant financial resources are spent. In other words, this approach will reduce the long-term costs associated with late diagnosis and subsequent treatment of the child. At the same time, the investment benefit of the widespread introduction of genetic screening technology in the framework of prenatal diagnostics will not be immediately apparent, but in the long term it will reduce the budget burden on the health system and lead to a General improvement of the population, which, in turn, will not only improve the quality of life of citizens, but also make a significant contribution to the development of the national economy.